Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8735034 | Transfusion and Apheresis Science | 2018 | 4 Pages |
Abstract
Severe neutropenia-associated invasive bacterial or fungal infections are still the major cause of mortality and morbidity in children receiving cancer chemotherapy. Granulocyte transfusion therapy has been used for many years in the management of neutropenic patients with severe infections in whom the clinical condition deteriorated despite appropriate antimicrobial treatment. Transfused granulocytes can increase the recipient's blood neutrophil count and accumulation of them into the site of infection. There are some data obtained from retrospective or prospective observational studies in pediatric granulocyte transfusion therapy, but results are not conclusive. This review appraises the potential benefits and risks of the use of granulocyte transfusion in children with neutropenic fever.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Dilek Gurlek Gokcebay, Sibel Akpinar Tekgunduz,